Reading Time: < 1 minuteIntroduction Chronic pain affects over 50 million American adults, with males comprising approximately 45% of cases, according to the Centers for Disease Control and Prevention (CDC). In U.S. males aged 40-65, conditions such as lower back pain, osteoarthritis, and neuropathic disorders predominate, often linked to occupational hazards, sedentary lifestyles, and metabolic syndrome. Traditional analgesics, including opioids and nonsteroidal anti-inflammatory drugs (NSAIDs), yield suboptimal outcomes, with opioid-related mortality rising 4-fold since 1999 per National Institute on Drug Abuse data. Omnitrope, a biosimilar recombinant human growth hormone (rhGH; somatropin), has garnered interest for its anabolic, anti-inflammatory, and neuroprotective properties. This longitudinal study … Continue reading →